Status:
COMPLETED
Perception & Acceptability of a Cervical Cancer Prevention Prebiotic Device
Lead Sponsor:
Glyciome, LLC
Collaborating Sponsors:
Brigham and Women's Hospital
University of Puerto Rico
Conditions:
Sensory Perceptual Characteristics
User Acceptability of Gel Delivery System
Eligibility:
FEMALE
30+ years
Phase:
NA
Brief Summary
PreBioGyn will be compared to market leading vaginal pH buffering gels using established forearm test methods associated with vaginal lubricity sensation in 42 women. Women will also rate each gel for...
Detailed Description
This study is being conducted as a component of a NIH/NCI sponsored Small Business Technology Transfer (STTR) project entitled "Cervical Cancer Prevention Prebiotic Device." The prebiotic vaginal gel...
Eligibility Criteria
Inclusion
- Female
- hrHPV positive
- 30 years of age or older
- Have not received the HPV vaccine
- Not pregnant or nursing
- Medicaid eligible
Exclusion
- history of skin irritation and/or allergic skin reactions
Key Trial Info
Start Date :
February 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04841629
Start Date
February 24 2022
End Date
November 28 2022
Last Update
December 6 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women'S Hospital
Boston, Massachusetts, United States, 02215
2
University of Puerto Rico Medical Sciences
San Juan, Puerto Rico, 00936